Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects-Reference-Cited by-同舟云学术

Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects

Published:2013-01 Issue:1 Volume:63 Page:111-120
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Salonen Arto J.,Taari Kimmo,Ala-Opas Martti,Viitanen Jouko,Lundstedt Seppo,Tammela Teuvo L.J.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer;Taylor;Cancer,2009

2. The FinnProstate Study VII: Intermittent versus continuous androgen deprivation in patients with advanced prostate cancer;Salonen;J Urol,2012

4. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation;Norman;Med Care,2003

5. The medical dictionary for regulatory activities (MedDRA);Brown;Drug Saf,1999

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-oncology in advanced prostate cancer;Frontiers in Oncology;2024-06-14

2. EORTC 2238 “De-Escalate”: a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors;Frontiers in Oncology;2024-05-08

3. 'Prehabilitation' checklist for men with prostate cancer starting androgen deprivation therapy;Trends in Urology & Men's Health;2024-03-21

4. Development of depression in patients using androgen deprivation therapy: A systemic review and meta‐analysis;The Prostate;2024-02-19

5. Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10-04